Daebong LS Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Daebong LS Company Limited with three other
companies in this sector in South Korea:
Humedix Co Ltd
sales of 64.83 billion Korean Won [US$57.12 million]
Sam-A Pharmaceutical Company
(66.95 billion Korean Won [US$58.98 million]
of which 87%
was Finished Goods), and
Pharma Reaserch Products Co Ltd
(64.28 billion Korean Won [US$56.63 million]
Daebong LS Company Limited reported sales of 71.82 billion Korean Won (US$63.28 million)
December of 2018.
increase of 9.4%
versus 2017, when the company's sales were 65.65 billion Korean Won.
Sales of Research saw an increase
that was more than double the company's growth rate: sales were up
20.5% in 2018, from
8.31 billion Korean Won to 10.02 billion Korean Won.
Not all segments of Daebong LS Company Limited experienced an increase in sales in 2018:
sales of Wholesale fell 24.6% to 504.24 million Korean Won.
(However, this segment's sales were only a very small portion of the company's overall sales).